DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/34chmv/emrs_and_clinical) has announced the addition of the "EMRs and Clinical Research: Current and Potential Impact" report to their offering.
This report provides the pharmaceutical industry and its service providers with novel insights into the current and future use of electronic medical records (EMRs) by clinical sites for clinical development.
While government incentive programs have driven the adoption of EMRs, ISR has found that investigative sites are still in the early stages of optimizing these technologies to positively impact clinical research, Andrew Schafer, President of ISR explained. ISR's newest report found that just because a medical practice has an EMR system installed, does not mean that they have integrated the system into the clinical research workflow.
The study study highlights significant opportunity for EMR vendors and trial sponsors. ISR surveyed 102 site coordinators and principal investigators with responsibility for clinical research and the analysis allows readers to:
- Learn how sites currently use EMRs for various clinical trial activities
- Understand the impact EMRs are having on patient recruitment and feasibility assessments
- Identify which EMR vendors are being used and which have the highest satisfaction ratings
- Uncover methods to better manage relationships with investigative sites
- Receive recommendations to improve trial efficiency
- Compare end-user satisfaction ratings across several major EMR platforms
For more information visit http://www.researchandmarkets.com/research/34chmv/emrs_and_clinical